Sitewide
T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia, according to researchers at Memorial Sloan-Kettering Cancer Center. By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
Similar Articles On This Topic:
- Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
- Twin nanoparticle shown effective at targeting, killing breast cancer cells
- Oncolytic viruses effectively target and kill pancreatic cancer stem cells
- Genetically engineered MSCs kill metastatic lung cancer cells in mice
- Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells
Popular Today:
Science 2.0:
- Science Can Save Crops, Forests And Endangered Animals By Doing This One Thing
- Organic Carbon In Meteorites Came From Mars
- Is That A Dragon In Your Berth Or Are You Just Happy To See Me?
- Are Anthropogenic Pressures Increasing The Speed Of Bacterial Evolution?
- From Towel Day To SpaceX And Transparency Grenades
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment